KCNJ12
Basic information
Region (hg38): 17:21376357-21419870
Previous symbols: [ "KCNJN1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNJ12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 17 | 28 | |||
missense | 11 | 18 | 30 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 11 | 12 | 36 |
Variants in KCNJ12
This is a list of pathogenic ClinVar variants found in the KCNJ12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-21415349-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
17-21415351-G-A | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415386-C-T | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415429-C-T | KCNJ12-related disorder | Benign (Oct 18, 2019) | ||
17-21415435-C-A | not specified | Uncertain significance (Jan 30, 2024) | ||
17-21415441-C-T | KCNJ12-related disorder | Likely benign (Sep 03, 2020) | ||
17-21415448-G-T | KCNJ12-related disorder | Benign (Oct 18, 2019) | ||
17-21415458-G-A | KCNJ12-related disorder | Benign (Oct 31, 2019) | ||
17-21415470-G-A | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415509-A-C | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415511-T-A | not specified | Uncertain significance (Dec 19, 2023) | ||
17-21415555-G-A | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415573-C-T | KCNJ12-related disorder | Likely benign (Jul 16, 2022) | ||
17-21415585-G-C | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415600-C-A | KCNJ12-related disorder | Benign (Nov 01, 2019) | ||
17-21415606-G-A | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415636-C-T | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415639-C-T | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415640-A-G | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415657-C-T | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415660-G-A | Likely benign (Aug 01, 2023) | |||
17-21415669-C-T | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415670-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
17-21415695-G-A | KCNJ12-related disorder | Benign (Oct 17, 2019) | ||
17-21415696-G-C | KCNJ12-related disorder | Benign (Oct 17, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KCNJ12 | protein_coding | protein_coding | ENST00000583088 | 1 | 43671 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0542 | 0.872 | 125484 | 0 | 264 | 125748 | 0.00105 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.16 | 175 | 224 | 0.781 | 0.0000158 | 2494 |
Missense in Polyphen | 74 | 92.981 | 0.79586 | 1092 | ||
Synonymous | 0.400 | 84 | 88.8 | 0.946 | 0.00000695 | 707 |
Loss of Function | 1.49 | 3 | 7.35 | 0.408 | 3.29e-7 | 93 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0150 | 0.0146 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000600 | 0.000598 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.000600 | 0.000598 |
South Asian | 0.00 | 0.00 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Inward rectifying potassium channel that is activated by phosphatidylinositol 4,5-bisphosphate and that probably participates in controlling the resting membrane potential in electrically excitable cells. Probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. {ECO:0000269|PubMed:12417321, ECO:0000269|PubMed:20921230, ECO:0000269|PubMed:7859381, ECO:0000269|PubMed:8647284}.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);Cholinergic synapse - Homo sapiens (human);Neuronal System;Phase 4 - resting membrane potential;Cardiac conduction;Muscle contraction;Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of GABAB receptors;GABA B receptor activation;GABA receptor activation;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Activation of G protein gated Potassium channels;Classical Kir channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels
(Consensus)
Recessive Scores
- pRec
- 0.177
Intolerance Scores
- loftool
- 0.0599
- rvis_EVS
- 1.56
- rvis_percentile_EVS
- 95.67
Haploinsufficiency Scores
- pHI
- 0.203
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.511
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Kcnj12
- Phenotype
Gene ontology
- Biological process
- potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane
- Cellular component
- plasma membrane;integral component of membrane;intrinsic component of membrane
- Molecular function
- inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity